|By Business Wire||
|July 29, 2014 04:03 PM EDT||
Castlight Health®, Inc. (NYSE:CSLT), a pioneer of the Enterprise Healthcare Cloud, today announced results for its second quarter ended June 30, 2014.
“Demand for Castlight’s Enterprise Healthcare Cloud remains strong as large organizations are increasingly evaluating enterprise healthcare technology to gain control of their healthcare spending,” said Giovanni Colella, M.D., co-founder and Chief Executive Officer of Castlight Health. “We ended the second quarter with 130 customers and expanded our Fortune 500 customer list by more than 20 percent. New large customers included Google, Kellogg Company, Texas Instruments and Sprint Corporation, among others. Further, we continue to execute well. We launched 13 additional customers during the second quarter, including CalPERS, and implemented Castlight Pharmacy and Castlight Rewards for 12 existing customers.”
Colella continued, “We continue to launch new products and lead the way with technologies that enable innovative benefit designs for our customers. We were pleased to announce the upcoming launch of Castlight Dental, which is the newest significant expansion of our Castlight Care Solution Center alongside Castlight Medical and Castlight Pharmacy.”
Financial Performance for the Three Months Ended June 30, 2014
- Total revenue for the second quarter of 2014 was $10.5 million, an increase of 353% from the second quarter of 2013. Subscription revenue was $9.6 million, an increase of 359% on a year-over-year basis. Professional services revenue was $1.0 million, an increase of 304% compared with the same period last year.
- Gross margin for the second quarter of 2014 was 29.6%, compared to a gross loss of 64.9% in the second quarter of 2013. Non-GAAP gross margin for the second quarter of 2014 was 32.6% compared to a gross loss of 63.9% in the second quarter of 2013.
- Operating loss for the second quarter of 2014 was $21.8 million, compared to an operating loss of $14.2 million during the second quarter of 2013. Non-GAAP operating loss for the second quarter of 2014 was $18.8 million, compared to a non-GAAP operating loss of $13.7 million during the second quarter of 2013.
- Net loss per basic and diluted share was ($0.24) in the second quarter of 2014, compared to a loss of ($1.47) per share in the second quarter of 2013. The non-GAAP net loss per share for the second quarter of 2014 was ($0.21), compared to a loss of ($1.43) per share in the second quarter of 2013. For both GAAP and non-GAAP purposes, the weighted average basic and diluted share count for the second quarter of 2014 was 89.5 million compared to 9.6 million in the second quarter of 2013.
- Total cash, cash equivalents and marketable securities were $217.9 million at the end of the second quarter of 2014, compared to $239.7 million at the end of last quarter. Cash used in operations for the second quarter of 2014 was $19.6 million, compared to $16.1 million used in operations last quarter.
A reconciliation of GAAP to non-GAAP results has been provided in this press release in the accompanying tables. An explanation of these measures is also included below under the heading “Non-GAAP Financial Measures”.
Q3 2014 Guidance: Revenue for the company’s third fiscal quarter is expected to be in the range of $11.3 million to $11.6 million, an increase of 214% to 222% year-over-year. Non-GAAP operating loss is expected to be in the range of ($18.7) million to ($19.0) million. Non-GAAP basic and diluted loss per share is expected to be approximately ($0.21) based on 90.0 million weighted average basic and diluted common shares outstanding.
Full Year 2014 Guidance: Revenue for the company’s full year 2014 is expected to be in the range of $42.6 million to $43.2 million, an increase of 228% to 232% year-over- year. Non-GAAP operating loss is expected to be in the range of ($75.0) million to ($76.0) million. Non-GAAP basic and diluted loss per share is expected to be in the range of ($1.00) to ($1.01) based on 75.0 million weighted average basic and diluted common shares outstanding.
For both the third quarter and the full year 2014, non-GAAP estimates exclude the effects of stock-based compensation expense and warrant expense.
Castlight Health announced today that Randy Womack, chief operating officer, will step down September 30, 2014 after nearly four years of service with the company. Mr. Womack’s responsibilities will be assumed by other members of Castlight’s management team after a seamless transition process is completed.
Additionally, Concur CEO Steve Singh has joined Castlight’s Board of Directors, effective immediately. Concurrently, directors Bob Kocher, M.D., partner at Venrock, and Christopher P. Michel, managing director at Nautilus Ventures, departed the Board. Dr. Kocher will remain as an advisor to the company, and Bryan Roberts, co-founder of Castlight and general partner at Venrock, remains Castlight’s Chairman of the Board. These changes follow the April addition of Ed Park, executive vice president and chief operating officer of athenahealth to the Board of Directors.
“We would like to thank Randy for his efforts to help make Castlight such a great company and achieve such strong momentum as a business. Randy has decided to leave the company with the success of his third IPO to pursue his passion for startups. We wish him every success in his future endeavors,” said Colella. “Moving forward, Castlight has an incredibly strong group of experienced, proven leaders. I look forward to working with them to continue to capture growth and realize innovation opportunities.”
Quarterly Conference Call
Castlight Health will host a conference call to discuss its second quarter results today at 2:00 p.m. Pacific Time (5:00 p.m. Eastern Time). A live audio webcast of the conference call, together with detailed financial information, can be accessed through the company's Investor Relations website at http://ir.castlighthealth.com. In addition, an archive of the audiocast can be accessed through the same link. Participants who choose to call in to the conference call can do so by dialing 1-201-689-8562. A replay will be available at 1-858-384-5517, passcode 13586458, until midnight (Eastern Time) August 5, 2014.
About Castlight Health
Castlight Health, Inc. (NYSE: CSLT) believes great healthcare builds great business. The Castlight Enterprise Healthcare Cloud enables employers to deliver cost-effective benefits, provides medical professionals and health plans a merit-based market to showcase their services, and – most importantly – empowers employees to make informed choices with a clear understanding of costs and likely outcomes. For more information visit www.castlighthealth.com. Follow us on Twitter and LinkedIn and Like us on Facebook. Source: Castlight Health.
Non-GAAP Financial Measures
To supplement Castlight Health’s financial statements presented in accordance with generally accepted accounting principles (GAAP), we also use and provide investors and others with non-GAAP measures of certain components of financial performance, including non-GAAP gross margin (loss), non-GAAP operating expense, non-GAAP operating loss and non-GAAP net loss per share. These non-GAAP financial measures differ from GAAP financial measures in that they exclude stock-based compensation, expense for a warrant issued to a third-party service provider and the associated tax impact of these items, where applicable.
We believe that these non-GAAP financial measures provide useful supplemental information to investors and others, facilitate the analysis of the company’s core operating results and comparison of operating results across reporting periods, and can help enhance overall understanding of the company’s historical financial performance.
We have provided a reconciliation of each non-GAAP financial measure to the most directly comparable GAAP financial measure, except that we have not reconciled our non-GAAP operating loss and net loss per share guidance for the third quarter and full fiscal year of 2014 to comparable GAAP operating loss and net loss per share guidance because we do not provide guidance for stock-based compensation expense and warrant expense, which are reconciling items between GAAP and non-GAAP operating loss. The factors that may impact our future stock-based compensation expense and warrant expense are out of our control and/or cannot be reasonably predicted, and therefore we are unable to provide such guidance without unreasonable effort.
These non-GAAP financial measures should be considered in addition to, not as a substitute for or in isolation from, measures prepared in accordance with GAAP. Further, these non-GAAP measures may differ from the non-GAAP information used by other companies, including peer companies, and therefore comparability may be limited. Castlight Health encourages investors and others to review the company’s financial information in its entirety and not rely on a single financial measure.
Safe Harbor For Forward-Looking Statements
This press release contains forward-looking statements about Castlight Health’s expectations, plans, intentions, and strategies, including, but not limited to, statements regarding Castlight Health’s third quarter and full year projections, our expectations for future performance of our business, market growth and business conditions, future innovation by the company and future developments with respect to the digital healthcare industry. Statements including words such as “anticipate,” “believe,” “estimate,” “will,” “continue,” “expect,” or “future,” and statements in the future tense are forward-looking statements. These forward-looking statements involve risks and uncertainties, as well as assumptions, which, if they do not fully materialize or prove incorrect, could cause our results to differ materially from those expressed or implied by such forward-looking statements. The risks and uncertainties include those described in Castlight Health’s documents filed with or furnished to the Securities and Exchange Commission. All forward-looking statements in this press release are based on information available to Castlight Health as of the date hereof. Castlight Health assumes no obligation to update these forward-looking statements.
Copyright 2014 Castlight Health, Inc. Castlight Health, Castlight, Castlight Medical, Castlight Pharmacy, Castlight Dental, Castlight Care Solution Center are trademarks and/or registered trademarks of Castlight Health Inc. in the United States and other countries. Other company and product names may be trademarks of the respective companies with which they are associated.
|CASTLIGHT HEALTH, INC.|
|CONDENSED CONSOLIDATED BALANCE SHEETS|
|June 30,||December 31,|
|Cash and cash equivalents||$||35,268||$||25,154|
|Accounts receivable, net||10,392||5,065|
|Prepaid expenses and other current assets||3,010||1,583|
|Total current assets||176,176||77,467|
|Property and equipment, net||3,164||2,631|
|Marketable securities, noncurrent||58,095||-|
Restricted cash, noncurrent
|Deferred commissions, noncurrent||1,648||1,821|
|Liabilities, convertible preferred stock and stockholders' equity (deficit)|
|Accrued expenses and other current liabilities||3,937||4,998|
|Total current liabilities||27,819||22,523|
|Deferred revenue, noncurrent||5,780||4,548|
|Other liabilities, noncurrent||317||373|
|Commitments and contingencies|
|Convertible preferred stock||-||180,423|
|Stockholders' equity (deficit)||205,547||(124,350||)|
|Total liabilities, convertible preferred stock and stockholders' equity (deficit)||$||239,463||$||83,517|
|CASTLIGHT HEALTH, INC.|
|CONDENSED CONSOLIDATED STATEMENTS OF OPERATIONS|
|(In thousands, except per share data)|
|Three Months Ended June 30,||Six Months Ended June 30,|
|Cost of revenue:|
|Cost of subscription (1)||2,915||1,460||5,627||2,664|
|Cost of professional services (1)||4,502||2,373||8,373||4,426|
|Total cost of revenue||7,417||3,833||14,000||7,090|
|Gross profit (loss)||3,116||(1,508||)||4,909||(2,858||)|
|Sales and marketing (1)||14,947||7,108||31,507||12,873|
|Research and development (1)||5,476||3,616||11,003||6,524|
|General and administrative (1)||4,519||1,981||8,529||3,441|
|Total operating expenses||24,942||12,705||51,039||22,838|
|Other income, net||50||40||73||90|
|Net loss per share, basic and diluted||$||(0.24||)||$||(1.47||)||$||(0.86||)||$||(2.71||)|
|Weighted-average shares used in basic and diluted net loss per share||89,520||9,619||53,284||9,438|
|(1)Includes stock-based compensation expense as follows:|
|Three Months Ended June 30,||Six Months Ended June 30,|
|Cost of revenue:|
|Cost of subscription||$||35||$||-||$||39||$||1|
|Cost of professional services||280||23||420||52|
|Sales and marketing||1,152||225||2,326||408|
|Research and development||493||61||914||110|
|General and administrative||980||156||1,794||272|
|CASTLIGHT HEALTH, INC.|
|CONDENSED CONSOLIDATED STATEMENTS OF CASH FLOWS|
|Three Months Ended June 30,||Six Months Ended June 30,|
|Adjustments to reconcile net loss to net cash used in operating activities:|
|Amortization of deferred commission||868||196||2,244||325|
|Accretion and amortization of marketable securities||373||193||497||421|
|Expense related to issuance of warrant||70||-||2,499||-|
|Changes in operating assets and liabilities:|
|Prepaid expenses and other assets||(596||)||(435||)||(1,677||)||(535||)|
|Accrued expenses and other liabilities||2,173||2,406||(1,203||)||1,109|
|Net cash used in operating activities||(19,574||)||(10,005||)||(35,635||)||(22,159||)|
|Decrease restricted cash, net||101||-||101||-|
|Purchase of property and equipment||(311||)||(408||)||(967||)||(1,118||)|
|Purchase of marketable securities||(126,442||)||(8,382||)||(162,175||)||(16,480||)|
|Sales of marketable securities||-||-||13,000||5,000|
|Maturities of marketable securities||3,000||39,075||8,000||44,075|
|Net cash (used in) provided by investing activities||(123,652||)||30,285||(142,041||)||31,477|
|Proceeds from the exercise of stock options||106||154||1,628||200|
|Payments of deferred financing costs||(1,679||)||-||(3,781||)||-|
Net proceeds from initial public offering
|Net cash (used in) provided by financing activities||(1,573||)||154||187,790||200|
|Net increase (decrease) in cash and cash equivalents||(144,799||)||20,434||10,114||9,518|
|Cash and cash equivalents at beginning of the period||180,067||31,618||25,154||42,534|
|Cash and cash equivalents at end of the period||$||35,268||$||52,052||$||35,268||$||52,052|
|CASTLIGHT HEALTH, INC.|
|RECONCILIATION OF GAAP TO NON-GAAP FINANCIAL MEASURES|
|(In thousands, except per share data)|
|Three Months Ended||Six Months Ended|
|June 30,||March 31,||June 30,||June 30,||June 30,|
|Gross profit (loss):|
GAAP gross profit subscription
|GAAP gross margin subscription||69.6||%||63.7||%||30.1||%||67.0||%||30.4||%|
|Stock-based compensation expense included in cost of revenue subscription||35||4||-||39||1|
|Non-GAAP gross profit subscription||$||6,696||$||4,755||$||628||$||11,451||$||1,164|
|Non-GAAP gross margin subscription||69.9||%||63.7||%||30.1||%||67.2||%||30.4||%|
|GAAP gross loss professional services||$||(3,545||)||$||(2,958||)||$||(2,136||)||$||(6,503||)||$||(4,021||)|
|GAAP gross loss percentage professional services||(370||)||%||(324||)||%||(901||)||%||(348||)||%||(993||)||%|
|Stock-based compensation expense included in cost of revenue professional services||280||140||23||420||52|
|Non-GAAP gross loss professional services||$||(3,265||)||$||(2,818||)||$||(2,113||)||$||(6,083||)||$||(3,969||)|
|Non-GAAP gross loss percentage professional services||(341||)||%||(309||)||%||(892||)||%||(325||)||%||(980||)||%|
|GAAP gross profit (loss)||$||3,116||$||1,793||$||(1,508||)||$||4,909||$||(2,858||)|
|GAAP gross margin (loss percentage)||29.6||%||21.4||%||(64.9||)||%||26.0||%||(67.5||)||%|
|Impact of non-GAAP adjustments||315||144||23||459||53|
|Non-GAAP gross profit (loss)||$||3,431||$||1,937||$||(1,485||)||$||5,368||$||(2,805||)|
|Non-GAAP gross margin (loss percentage)||32.6||%||23.1||%||(63.9||)||%||28.4||%||(66.3||)||%|
|GAAP sales and marketing||$||14,947||$||16,560||$||7,108||$||31,507||$||12,873|
|Expense related to warrant||(70||)||(2,429||)||-||(2,499||)||-|
|Stock-based compensation expense included in sales and marketing||(1,152||)||(1,174||)||(225||)||(2,326||)||(408||)|
|Non-GAAP sales and marketing||$||13,725||$||12,957||$||6,883||$||26,682||$||12,465|
|GAAP research and development||$||5,476||$||5,527||$||3,616||$||11,003||$||6,524|
|Stock-based compensation expense included in research and development||(493||)||(421||)||(61||)||(914||)||(110||)|
|Non-GAAP research and development||$||4,983||$||5,106||$||3,555||$||10,089||$||6,414|
|GAAP general and administrative||$||4,519||$||4,010||$||1,981||$||8,529||$||3,441|
|Stock-based compensation expense included in general and administrative||(980||)||(814||)||(156||)||(1,794||)||(272||)|
|Non-GAAP general and administrative||$||3,539||$||3,196||$||1,825||$||6,735||$||3,169|
|GAAP operating expenses||$||24,942||$||26,097||$||12,705||$||51,039||$||22,838|
|Impact of non-GAAP adjustments||(2,695||)||(4,838||)||(442||)||(7,533||)||(790||)|
|Non-GAAP operating expenses||$||22,247||$||21,259||$||12,263||$||43,506||$||22,048|
|GAAP operating loss||$||(21,826||)||$||(24,304||)||$||(14,213||)||$||(46,130||)||$||(25,696||)|
|Impact of non-GAAP adjustments||3,010||4,982||465||7,992||843|
|Non-GAAP operating loss||$||(18,816||)||$||(19,322||)||$||(13,748||)||$||(38,138||)||$||(24,853||)|
|Net loss and net loss per share:|
|GAAP net loss||$||(21,776||)||$||(24,281||)||$||(14,173||)||$||(46,057||)||$||(25,606||)|
|Total pre-tax impact of non-GAAP adjustments||3,010||4,982||465||7,992||843|
|Income tax impact of non-GAAP adjustments||-||-||-||-||-|
|Non-GAAP net loss||$||(18,766||)||$||(19,299||)||$||(13,708||)||$||(38,065||)||$||(24,763||)|
|Basic and Diluted net loss per share|
|Shares used in basic and diluted net loss per share computation||89,520||26,970||9,619||53,284||9,438|
|Free Cash Flow|
|GAAP net cash flow used in operating activities||$||(19,574||)||$||(16,061||)||$||(10,005||)||$||(35,635||)||$||(22,159||)|
|Purchase of property and equipment||(311||)||(656||)||(408||)||(967||)||(1,118||)|
|Free cash flow||$||(19,885||)||$||(16,717||)||$||(10,413||)||$||(36,602||)||$||(23,277||)|
In his session at @ThingsExpo, Eric Lachapelle, CEO of the Professional Evaluation and Certification Board (PECB), will provide an overview of various initiatives to certifiy the security of connected devices and future trends in ensuring public trust of IoT. Eric Lachapelle is the Chief Executive Officer of the Professional Evaluation and Certification Board (PECB), an international certification body. His role is to help companies and individuals to achieve professional, accredited and worldw...
Mar. 24, 2017 08:15 PM EDT Reads: 218
DevOps is often described as a combination of technology and culture. Without both, DevOps isn't complete. However, applying the culture to outdated technology is a recipe for disaster; as response times grow and connections between teams are delayed by technology, the culture will die. A Nutanix Enterprise Cloud has many benefits that provide the needed base for a true DevOps paradigm.
Mar. 24, 2017 08:00 PM EDT Reads: 1,495
My team embarked on building a data lake for our sales and marketing data to better understand customer journeys. This required building a hybrid data pipeline to connect our cloud CRM with the new Hadoop Data Lake. One challenge is that IT was not in a position to provide support until we proved value and marketing did not have the experience, so we embarked on the journey ourselves within the product marketing team for our line of business within Progress. In his session at @BigDataExpo, Sum...
Mar. 24, 2017 06:30 PM EDT Reads: 2,599
Your homes and cars can be automated and self-serviced. Why can't your storage? From simply asking questions to analyze and troubleshoot your infrastructure, to provisioning storage with snapshots, recovery and replication, your wildest sci-fi dream has come true. In his session at @DevOpsSummit at 20th Cloud Expo, Dan Florea, Director of Product Management at Tintri, will provide a ChatOps demo where you can talk to your storage and manage it from anywhere, through Slack and similar services ...
Mar. 24, 2017 06:30 PM EDT Reads: 4,099
What sort of WebRTC based applications can we expect to see over the next year and beyond? One way to predict development trends is to see what sorts of applications startups are building. In his session at @ThingsExpo, Arin Sime, founder of WebRTC.ventures, will discuss the current and likely future trends in WebRTC application development based on real requests for custom applications from real customers, as well as other public sources of information,
Mar. 24, 2017 05:30 PM EDT Reads: 365
SYS-CON Events announced today that SoftLayer, an IBM Company, has been named “Gold Sponsor” of SYS-CON's 18th Cloud Expo, which will take place on June 7-9, 2016, at the Javits Center in New York, New York. SoftLayer, an IBM Company, provides cloud infrastructure as a service from a growing number of data centers and network points of presence around the world. SoftLayer’s customers range from Web startups to global enterprises.
Mar. 24, 2017 05:15 PM EDT Reads: 1,287
SYS-CON Events announced today that Ocean9will exhibit at SYS-CON's 20th International Cloud Expo®, which will take place on June 6-8, 2017, at the Javits Center in New York City, NY. Ocean9 provides cloud services for Backup, Disaster Recovery (DRaaS) and instant Innovation, and redefines enterprise infrastructure with its cloud native subscription offerings for mission critical SAP workloads.
Mar. 24, 2017 04:45 PM EDT Reads: 1,759
Have you ever noticed how some IT people seem to lead successful, rewarding, and satisfying lives and careers, while others struggle? IT author and speaker Don Crawley uncovered the five principles that successful IT people use to build satisfying lives and careers and he shares them in this fast-paced, thought-provoking webinar. You'll learn the importance of striking a balance with technical skills and people skills, challenge your pre-existing ideas about IT customer service, and gain new in...
Mar. 24, 2017 04:30 PM EDT Reads: 2,253
SYS-CON Events announced today that Juniper Networks (NYSE: JNPR), an industry leader in automated, scalable and secure networks, will exhibit at SYS-CON's 20th International Cloud Expo®, which will take place on June 6-8, 2017, at the Javits Center in New York City, NY. Juniper Networks challenges the status quo with products, solutions and services that transform the economics of networking. The company co-innovates with customers and partners to deliver automated, scalable and secure network...
Mar. 24, 2017 04:30 PM EDT Reads: 1,026
Interoute has announced the integration of its Global Cloud Infrastructure platform with Rancher Labs’ container management platform, Rancher. This approach enables enterprises to accelerate their digital transformation and infrastructure investments. Matthew Finnie, Interoute CTO commented “Enterprises developing and building apps in the cloud and those on a path to Digital Transformation need Digital ICT Infrastructure that allows them to build, test and deploy faster than ever before. The int...
Mar. 24, 2017 04:30 PM EDT Reads: 497
VeriStor Systems has announced that CRN has named VeriStor to its 2017 Managed Service Provider (MSP) 500 list in the Elite 150 category. This annual list recognizes North American solution providers with cutting-edge approaches to delivering managed services. Their offerings help companies navigate the complex and ever-changing landscape of IT, improve operational efficiencies, and maximize their return on IT investments. In today’s fast-paced business environments, MSPs play an important role...
Mar. 24, 2017 03:00 PM EDT Reads: 2,106
DevOps is often described as a combination of technology and culture. Without both, DevOps isn't complete. However, applying the culture to outdated technology is a recipe for disaster; as response times grow and connections between teams are delayed by technology, the culture will die. A Nutanix Enterprise Cloud has many benefits that provide the needed base for a true DevOps paradigm. In his Day 3 Keynote at 20th Cloud Expo, Chris Brown, a Solutions Marketing Manager at Nutanix, will explore t...
Mar. 24, 2017 02:45 PM EDT Reads: 2,543
What if you could build a web application that could support true web-scale traffic without having to ever provision or manage a single server? Sounds magical, and it is! In his session at 20th Cloud Expo, Chris Munns, Senior Developer Advocate for Serverless Applications at Amazon Web Services, will show how to build a serverless website that scales automatically using services like AWS Lambda, Amazon API Gateway, and Amazon S3. We will review several frameworks that can help you build serverle...
Mar. 24, 2017 01:30 PM EDT Reads: 1,541
SYS-CON Events announced today that Linux Academy, the foremost online Linux and cloud training platform and community, will exhibit at SYS-CON's 20th International Cloud Expo®, which will take place on June 6-8, 2017, at the Javits Center in New York City, NY. Linux Academy was founded on the belief that providing high-quality, in-depth training should be available at an affordable price. Industry leaders in quality training, provided services, and student certification passes, its goal is to c...
Mar. 24, 2017 01:15 PM EDT Reads: 3,835
SYS-CON Events announced today that Interoute, owner-operator of one of Europe's largest networks and a global cloud services platform, has been named “Bronze Sponsor” of SYS-CON's 20th Cloud Expo, which will take place on June 6-8, 2017 at the Javits Center in New York, New York. Interoute is the owner-operator of one of Europe's largest networks and a global cloud services platform which encompasses 12 data centers, 14 virtual data centers and 31 colocation centers, with connections to 195 add...
Mar. 24, 2017 01:15 PM EDT Reads: 554